Newsroom

Industry News

24 Apr

Nephros Announces Partnership with WorldWater & Solar Technologies

RIVER EDGE, NJ–(Marketwired – Apr 24, 2017) –  Nephros, Inc. ( OTCQB : NEPH ) (the “Company”), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters, and WorldWater & Solar Technologies, Inc., a leader in integrated solar platform technology that uses sunshine to...

Read more

21 Apr

Onconova Therapeutics Announces Pricing of Public Offering of Common Stock

NEWTOWN, Pa., April 21, 2017 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. (ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing small molecule drug candidates to treat cancer, with a primary focus on Myelodysplastic Syndromes (MDS) today announced that it has priced an underwritten public offering of...

Read more

21 Apr

Youngevity Moves up to #76 in 2016 Global Direct Sales 100

SAN DIEGO, CA–(Marketwired – Apr 21, 2017) – Youngevity International, Inc. ( OTCQX : YGYI ), a leading omni-direct lifestyle company, was named the 76th largest direct selling company in the world for 2016 by top industry trade publication Direct Selling News.  The Direct Selling News Global 100 is an...

Read more

20 Apr

Mateon Announces Initiation of Investigator-Sponsored Phase 1 Study of CA4P in Combination with Everolimus in Neuroendocrine Tumors

SOUTH SAN FRANCISCO, Calif., April 20, 2017 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of orphan oncology indications, today announced that the Markey Cancer Center at the University of Kentucky has enrolled the first patient into a new...

Read more

18 Apr

Mateon Therapeutics Announces Encouraging Results from First Interim Analysis of Phase 2/3 FOCUS Study in Platinum-resistant Ovarian Cancer

SOUTH SAN FRANCISCO, Calif., April 18, 2017 (GLOBE NEWSWIRE) — Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of orphan oncology indications, today announced interim data from its first scheduled analysis of the ongoing Phase 2/3 study (FOCUS) in patients with platinum...

Read more

18 Apr

Actinium Pharmaceuticals Announces Sponsorship of the Acute Leukemia Forum 2017

NEW YORK, April 18, 2017 (GLOBE NEWSWIRE) — Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical Company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, announced today that Actinium is a sponsor of the Acute Leukemia Forum 2017 being held in San Francisco,...

Read more

18 Apr

IsoRay, Inc. to Present at the Planet MicroCap Showcase 2017

NEW YORK, NY / ACCESSWIRE / April 18, 2017 / IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment of prostate, brain, lung, head and neck, and gynecological cancers, today announced that it will be presenting at...

Read more

Page 1 of 22712345...102030...Last »

Enter your email address to receive notifications of new posts by email.

Latest Tweets

Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address